Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.45 |
| ▸ | TYK2 | P29597 | 14/20 | 0.44 |
| ▸ | JAK3 | P52333 | 14/20 | 0.44 |
| ▸ | JAK1 | P23458 | 12/20 | 0.44 |
| ▸ | JAK2 | O60674 | 11/20 | 0.44 |
| ▸ | AURKA | O14965 | 4/20 | 0.44 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.44 |
| ▸ | PLK4 | O00444 | 1/20 | 0.37 |
| ▸ | PAK4 | O96013 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30147236 | 0.90 | GPR119 (0.55) | GPR119TYK2JAK3JAK1JAK2 | |
| SCHEMBL22055034 | 0.90 | GPR119 (0.55) | GPR119TYK2JAK3JAK1JAK2 | |
| SCHEMBL30147261 | 0.87 | GPR119 (0.52) | GPR119TYK2JAK3JAK1JAK2 | |
| SCHEMBL23878805 | 0.83 | AURKA (0.53) | TYK2JAK3JAK1JAK2AURKA | |
| SCHEMBL30147224 | 0.80 | GPR119 (0.52) | GPR119TYK2JAK3JAK1JAK2 | |
| SCHEMBL22054197 | 0.80 | GPR119 (0.52) | GPR119TYK2JAK3JAK1JAK2 | |
| SCHEMBL22054573 | 0.80 | GPR119 (0.53) | GPR119TYK2JAK3JAK1JAK2 | |
| SCHEMBL30147229 | 0.80 | GPR119 (0.53) | GPR119TYK2JAK3JAK1JAK2 | |
| SCHEMBL22054571 | 0.80 | AURKA (0.56) | TYK2JAK3JAK1JAK2AURKA | |
| SCHEMBL23878775 | 0.80 | AURKA (0.51) | TYK2JAK3JAK1JAK2AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021238908-A1 | SALT AND CRYSTAL FORM OF HETEROARYL DERIVATIVE, AND PREPARATION METHOD THEREFOR | 上海翰森生物医药科技有限公司 | 2021-12-02 | — | — | WO | disclosed |